Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Wierda

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Leukemia|October 26, 2013
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitorsM A Kharfan-Dabaja, W G Wierda, L J N Cooper
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Induction of porcine granulocyte-mediated tumor cytotoxicity by two distinct monoclonal antibodies against lytic trigger molecules (PNK-E/G7)W G Wierda, B D Johnson, M E Dato, et al.
Cellular Immunology|February 1, 1993
Two distinct porcine natural killer lytic trigger molecules as PNK-E/G7 molecular complexW G Wierda, B D Johnson, M E Dato, et al.
Leukemia|August 23, 2001
T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154M J Cantwell, W G Wierda, I S Lossos, et al.
Blood|October 26, 2000
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemiaW G Wierda, M J Cantwell, S J Woods, et al.
Leukemia|August 12, 2005
Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemiaM Motta, L Rassenti, B J Shelvin, et al.
Leukemia|October 1, 2010
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154W G Wierda, J E Castro, R Aguillon, et al.
Leukemia|October 16, 2004
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabineJ S Carew, S T Nawrocki, R H Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Leukemia|October 26, 2013
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitorsM A Kharfan-Dabaja, W G Wierda, L J N Cooper
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Induction of porcine granulocyte-mediated tumor cytotoxicity by two distinct monoclonal antibodies against lytic trigger molecules (PNK-E/G7)W G Wierda, B D Johnson, M E Dato, et al.
Cellular Immunology|February 1, 1993
Two distinct porcine natural killer lytic trigger molecules as PNK-E/G7 molecular complexW G Wierda, B D Johnson, M E Dato, et al.
Leukemia|August 23, 2001
T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154M J Cantwell, W G Wierda, I S Lossos, et al.
Blood|October 26, 2000
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemiaW G Wierda, M J Cantwell, S J Woods, et al.
Leukemia|August 12, 2005
Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemiaM Motta, L Rassenti, B J Shelvin, et al.
Leukemia|October 1, 2010
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154W G Wierda, J E Castro, R Aguillon, et al.
Leukemia|October 16, 2004
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabineJ S Carew, S T Nawrocki, R H Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Pageof 4